Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Janice Faulkner"'
Publikováno v:
Clinical and Translational Science, Vol 13, Iss 3, Pp 539-546 (2020)
The objective of this study was to determine the effect of concomitant alcohol intake on the bioavailability of oxycodone from an oxycodone once‐daily (OOD) formulation and an oxycodone twice‐daily (OTD) formulation. A phase I, open‐label, rand
Externí odkaz:
https://doaj.org/article/c4d583a8f77e4320b4d1449e31b91900
Publikováno v:
Clinical and Translational Science, Vol 13, Iss 3, Pp 539-546 (2020)
Clinical and Translational Science
Clinical and Translational Science
The objective of this study was to determine the effect of concomitant alcohol intake on the bioavailability of oxycodone from an oxycodone once‐daily (OOD) formulation and an oxycodone twice‐daily (OTD) formulation. A phase I, open‐label, rand
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c49cdbbec32edc22192afcd2cc3607e6
https://doaj.org/article/c4d583a8f77e4320b4d1449e31b91900
https://doaj.org/article/c4d583a8f77e4320b4d1449e31b91900
Autor:
Kevin P. Becker, John D. Hainsworth, Tarek Mekhail, David Wright, Howard A. Burris, Sajeel A. Chowdhary, Janice Faulkner Eakle, Kimberly West-Osterfield, Gilbert Darin Anthony Padula, Mythili Shastry, Meredith Scarberry, Kent C. Shih, Robert M. Langdon, Candice A. Shaifer, Kathleen Yost
Publikováno v:
Journal of Neuro-Oncology. 144:303-311
Current bevacizumab-based regimens have failed to improve survival in patients with recurrent glioblastoma. To improve treatment efficacy, we evaluated bevacizumab + BKM120, an oral pan-class I PI3K inhibitor, in this patient population. A brief phas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c845679595802fdeb2f9fdd0010e6b21
https://doi.org/10.1007/s11060-019-03227-7
https://doi.org/10.1007/s11060-019-03227-7
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Janice Faulkner, Kerri A. Schoedel, Hailong Cheng, Bijan Chakaraborty, Talar Hopyan, Naama Levy-Cooperman, David Blum
Publikováno v:
Drug and Alcohol Dependence. 146:e224
Aims: Naltrexone is a ffJ-opioid receptor antagonist that blocks the euphoric effects of heroin and opioids. Opioid craving, depression, anxiety, and anhedonia are triggers for relapse and dropping out of treatment. It is important to evaluate the ef
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0fbfc0fc2ec4a783bb51c4570b17e74f
https://doi.org/10.1016/j.drugalcdep.2014.09.077
https://doi.org/10.1016/j.drugalcdep.2014.09.077
Publikováno v:
North Carolina Medical Journal. 69:63-63
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::667bf519f8e7dd6d727db7946c8e524d
https://doi.org/10.18043/ncm.69.1.63
https://doi.org/10.18043/ncm.69.1.63
Autor:
Janice Faulkner Eakle, Lung T. Yam
Publikováno v:
Southern Medical Journal. 92:S55
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1f35b4c4f07c46c920e7d7ae02896194
https://doi.org/10.1097/00007611-199911001-00119
https://doi.org/10.1097/00007611-199911001-00119
Publikováno v:
Southern Medical Journal. 92:S41
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::73ebf7c5a3c53590cc61d914c701f9bd
https://doi.org/10.1097/00007611-199911001-00084
https://doi.org/10.1097/00007611-199911001-00084